Zoledronate Prevents Morphometric Vertebral Fractures Over 10 Years
Zoledronate administered at baseline and five years effective for preventing fragility fracture, any fracture, major osteoporotic fracture
Glucarpidase Improves Outcomes in Patients With Methotrexate-Induced Kidney Toxicity
Glucarpidase associated with 2.70-fold increased odds of kidney recovery in methotrexate-acute kidney injury
TACE + Lenvatinib, Pembrolizumab Tied to Improved Survival in Unresectable Liver Cancer
Clinically meaningful improvement seen in progression-free survival for transarterial chemoembolization plus lenvatinib and pembrolizumab
Vaccination Does Not Impact Long COVID Neurological Symptoms
Minor differences in neurologic symptoms seen between prevaccination infection and breakthrough infection
2015 to 2022 Saw Rise in Ketamine Use
Association with depression attenuated in later years, while new sociodemographic risk factors emerged
Differences Exist in Precision Oncology Drug Eligibility Among Patient Ancestral Groups
Patients of African ancestry had the lowest precision oncology drug-based clinical actionability from 2019 onward
Semaglutide Doubles Risk for Nonarteritic Anterior Ischemic Optic Neuropathy
Findings seen for patients with type 2 diabetes during a five-year period
Interviews ID Factors Tied to COVID-19 Vaccine Hesitancy in Black Women
Mistrust in health care and government, concerns over vaccine safety and long-term effects among top factors
MEK Inhibition Beneficial for Children With Subset of Severe Hypertrophic Cardiomyopathy
Decrease in mortality, morbidity seen with trametinib for children with RASopathy-associated hypertrophic cardiomyopathy
Shorter Treatment Regimens Recommended for Tuberculosis
Four-month regimen recommended for drug-susceptible TB and six-month regimen recommended for drug-resistant TB
